Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants

AIM: The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over the HeartMate II axial‐flow pump. We now evaluate HM3 LVAD outcomes in a single‐arm prospective continuous access proto...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehra, Mandeep R., Cleveland, Joseph C., Uriel, Nir, Cowger, Jennifer A., Hall, Shelley, Horstmanshof, Douglas, Naka, Yoshifumi, Salerno, Christopher T., Chuang, Joyce, Williams, Christopher, Goldstein, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Lvad
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453814/
https://www.ncbi.nlm.nih.gov/pubmed/33932272
http://dx.doi.org/10.1002/ejhf.2211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453814/
https://www.ncbi.nlm.nih.gov/pubmed/33932272
http://dx.doi.org/10.1002/ejhf.2211

Ejemplares similares